Patents by Inventor Yutaka Miura

Yutaka Miura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11255867
    Abstract: A movable piece includes a front arm and a rear arm. In a first process, the front arm retreats from a conveying path to permit forward movement of an n-th holder, and in a second process advances into the conveying path to restrict forward movement of an n+1-th holder. In the first process, the rear arm advances into the conveying path to restrict forward movement of the n-th holder, and in the second process retreats from the conveying path 18 to permit forward movement of the n-th holder. Midway through the second process, the n-th holder 84 is positioned in a reference stopping position.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: February 22, 2022
    Assignee: Hitachi, Ltd.
    Inventors: Yutaka Miura, Yuichi Takanami
  • Publication number: 20210364539
    Abstract: A movable piece includes a front arm and a rear arm. In a first process, the front arm retreats from a conveying path to permit forward movement of an n-th holder, and in a second process advances into the conveying path to restrict forward movement of an n+1-th holder. In the first process, the rear arm advances into the conveying path to restrict forward movement of the n-th holder, and in the second process retreats from the conveying path 18 to permit forward movement of the n-th holder. Midway through the second process, the n-th holder 84 is positioned in a reference stopping position.
    Type: Application
    Filed: November 8, 2018
    Publication date: November 25, 2021
    Applicant: Hitachi, Ltd.
    Inventors: Yutaka Miura, Yuichi Takanami
  • Patent number: 10220026
    Abstract: The problem addressed by the present invention is to develop a pharmaceutical having therapeutic efficacy against epirubicin-resistant tumors. The present invention provides a micelle having an anti-cancer agent disposed inside the core of the micelle formed by an epirubicin-conjugated copolymer.
    Type: Grant
    Filed: August 11, 2015
    Date of Patent: March 5, 2019
    Assignees: THE UNIVERSITY OF TOKYO, TOKYO INSTITUTE OF TECHNOLOGY
    Inventors: Hiroaki Kinoh, Kazunori Kataoka, Horacio Cabral, Yutaka Miura, Shigeto Fukushima, Nobuhiro Nishiyama, Tsukasa Chida
  • Patent number: 9920133
    Abstract: Monoclonal antibodies against human and mouse tissue factor, and fragments thereof, are disclosed, as well as pharmaceutical compositions and compositions for drug delivery containing the same. Therapeutic methods using the same are also disclosed.
    Type: Grant
    Filed: February 3, 2015
    Date of Patent: March 20, 2018
    Assignees: NATIONAL CANCER CENTER, The University of Tokyo, RIKEN, NanoCarrier Co., Ltd.
    Inventors: Yasuhiro Matsumura, Masahiro Yasunaga, Yoshikatsu Koga, Yoshiyuki Yamamoto, Ryuta Sato, Ryo Tsumura, Kazunori Kataoka, Nobuhiro Nishiyama, Yutaka Miura, Shino Manabe, Yasuki Kato
  • Patent number: 9801958
    Abstract: The present invention provides a safe polymer nanoparticle composite with few side effects, and an MRI contrast agent incorporating said polymer nanoparticle composite. The polymer nanoparticle composite is capable of specifically accumulating on a tumor tissue to selectively extract the tissue, exhibiting high contrast even when used in small amounts, and enabling imaging over prolonged periods of time. This polymer nanoparticle composite is characterized by containing a block copolymer that includes a non-charged hydrophilic polymer chain segment and an anionic polymer chain segment, and MnCaP.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: October 31, 2017
    Assignee: THE UNIVERSITY OF TOKYO
    Inventors: Kazunori Kataoka, Nobuhiro Nishiyama, Horacio Cabral, Peng Mi, Akihiro Kishimura, Yutaka Miura, Ichio Aoki, Daisuke Kokuryo, Tsuneo Saga
  • Publication number: 20170258922
    Abstract: The problem addressed by the present invention is to develop a pharmaceutical having therapeutic efficacy against epirubicin-resistant tumors. The present invention provides a micelle having an anti-cancer agent disposed inside the core of the micelle formed by an epirubicin-conjugated copolymer.
    Type: Application
    Filed: August 11, 2015
    Publication date: September 14, 2017
    Inventors: Hiroaki Kinoh, Kazunori Kataoka, Horacio Cabral, Yutaka Miura, Shigeto Fukushima, Nobuhiro Nishiyama, Tsukasa Chida
  • Publication number: 20160333113
    Abstract: Monoclonal antibodies against human and mouse tissue factor, and fragments thereof, are disclosed, as well as pharmaceutical compositions and compositions for drug delivery containing the same. Therapeutic methods using the same are also disclosed.
    Type: Application
    Filed: February 3, 2015
    Publication date: November 17, 2016
    Applicants: NATIONAL CANCER CENTER, The University of Tokyo, RIKEN, NanoCarrier Co., Ltd.
    Inventors: Yasuhiro MATSUMURA, Masahiro YASUNAGA, Yoshikatsu KOGA, Yoshiyuki YAMAMOTO, Ryuta SATO, Ryo TSUMURA, Kazunori KATAOKA, Nobuhiro NISHIYAMA, Yutaka MIURA, Shino MANABE, Yasuki KATO
  • Publication number: 20160206759
    Abstract: The present invention provides a safe polymer nanoparticle composite with few side effects, and an MRI contrast agent incorporating said polymer nanoparticle composite. The polymer nanoparticle composite is capable of specifically accumulating on a tumor tissue to selectively extract the tissue, exhibiting high contrast even when used in small amounts, and enabling imaging over prolonged periods of time. This polymer nanoparticle composite is characterized by containing a block copolymer that includes a non-charged hydrophilic polymer chain segment and an anionic polymer chain segment, and MnCaP.
    Type: Application
    Filed: August 22, 2014
    Publication date: July 21, 2016
    Applicant: THE UNIVERSITY OF TOKYO
    Inventors: Kazunori KATAOKA, Nobuhiro NISHIYAMA, Horacio CABRAL, Peng MI, Akihiro KISHIMURA, Yutaka MIURA, Ichio AOKI, Daisuke KOKURYO, Tsuneo SAGA
  • Publication number: 20120156887
    Abstract: A vacuum processing apparatus, comprising: a processing chamber 3 in which an object to be processed is placed and a predetermined vacuum state is formed; a first processing gas introducing means 12 for converting a first processing gas into a radical state and introducing the resulting first processing gas in the radical state into the processing chamber through first processing gas introducing ports which open to the interior of the processing chamber; a second processing gas introducing means 15 for introducing a second processing gas, which is reactive with the first processing gas in the radical state, into the processing chamber through second processing gas introducing ports which open to the interior of the processing chamber; a temperature controlling means for controlling the temperature within the processing chamber 3 to a first temperature-controlled state, in which the first processing gas in the radical state and the second processing gas process the surface of the object to be processed, thereb
    Type: Application
    Filed: August 24, 2010
    Publication date: June 21, 2012
    Inventors: Youhei Ono, Masaaki Kawana, Yutaka Miura
  • Patent number: 8097541
    Abstract: Native oxide film on a semiconductor silicon wafer(s) is dry etched at a temperature of 50° C. or less. Hydrogen treatment is then carried out a temperature of 100° C. or more to bond the dangling bonds with hydrogen. A jig 9 that has been used is again used for loading new semiconductor silicon wafer(s) 10. The wafer(s) on the jig 9 is subjected to removal of a native oxide film and then hydrogen bonding. The resultant heat remains in jig and makes it difficult to maintain the wafers to temperature appropriate to removal of a native oxide film. After treatment of hydrogen bonding, inert gas having temperature of from 0 to ?30° C. is injected into reaction vessel 5 and/or treatment preparing vessel 21, in which a native oxide film has been removed.
    Type: Grant
    Filed: August 15, 2006
    Date of Patent: January 17, 2012
    Assignees: F.T.L. Co., Ltd., ULVAC, Inc.
    Inventors: Mikio Takagi, Seiichi Takahashi, Hiroaki Inoue, Masayuki Satou, Yutaka Miura
  • Patent number: 7871788
    Abstract: Means for easily determining the grade of malignancy of cancer cells. The amount of ATBF1 in the whole cell structure of test cancer cells separated from a living organism is detected, and on the basis of detection results, the grade of malignancy of test cancer cells is judged. Alternatively, the amount of ATBF1 in the nuclei of test cancer cells separated from a living organism is detected, and on the basis of detection results, the grade of malignancy of test cancer cells is judged. Still alternatively, the amount of ATBF1 in the cytoplasms of test cancer cells separated from a living organism is detected, and on the basis of detection results, the grade of malignancy of test cancer cells is judged.
    Type: Grant
    Filed: July 29, 2005
    Date of Patent: January 18, 2011
    Assignee: Nagoya Industrial Science Research Institute
    Inventors: Yutaka Miura, Makoto Kawaguchi, Hirotaka Iwase, Minoru Hamazaki, Jung Cha-Gyun, Hitoo Nishino
  • Patent number: 7828016
    Abstract: A process gas line (255) for carrying WF6 gas for nucleation, a process gas line (259) for carrying WF6 gas for film deposition after nucleation are joined at a single joint (280) to a carrier gas line (256). A gas line (270) is connected to the joint (280) to carry a mixed gas of the carrier gas and WF6 gas to a processing chamber defined by a processing vessel. Sections of the carrier gas line (256) and the gas line (270) extending on the opposite sides of the joint (280) extend along a straight line, and the process gas lines (255, 259) are perpendicular to the gas line (270).
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: November 9, 2010
    Assignee: Tokyo Electron Limited
    Inventors: Hayashi Otsuki, Yutaka Miura
  • Publication number: 20100080862
    Abstract: It is intended to provide compositions and foods for use in the treatment, prophylaxis, or amelioration of diseases or symptoms which can be treated, prevented or ameliorated by activating PPAR, in particular, insulin resistant diabetes and hyperlipidemia. Namely, medicinal compositions usable in treating, preventing or improving diseases or symptoms which can be treated, prevented or ameliorated by activation PPAR which contain humulones, isohumulones or lupulones or pharmaceutically acceptable salts or solvates thereof.
    Type: Application
    Filed: September 10, 2009
    Publication date: April 1, 2010
    Inventors: Hiroaki YAJIMA, Yutaka Miura, Daisuke Fujiwara, Hideharu Odai, Keiji Kondo, Hajime Nozawa
  • Patent number: 7585558
    Abstract: The present invention discloses: a composition comprising (A) an epoxy group-containing vinyl ester resin having, in the molecule, 0.8 to 0.3 equivalent of epoxy group and 0.2 to 0.7 equivalent of an ethylenically unsaturated group, (B) a radical-polymerizable monomer, (C) a curing agent, and (D) a carbon fiber impregnated with 0.5 to 5% by mass of (d) a vinyl ester resin as a sizing agent, obtained by an addition reaction of an epoxy resin and an ethylenically unsaturated carboxylic acid, and a carbon fiber-reinforced resin composite material produced by curing the above composition.
    Type: Grant
    Filed: January 28, 2004
    Date of Patent: September 8, 2009
    Assignees: Toho Tenax Co., Ltd., Showa Highpolymer Co., Ltd.
    Inventors: Yoshinori Suzuki, Yutaka Miura, Katsura Horikoshi, Mitsuhiro Yada
  • Publication number: 20090117747
    Abstract: [Task] Native oxide film on a semiconductor silicon wafer(s) is dry etched at a temperature of 50° C. or less. Hydrogen treatment is then carried out a temperature of 100° C. or more to bond the dangling bonds with hydrogen. A jig 9 that has been used is again used for loading new semiconductor silicon wafer(s) 10. The wafer(s) on the jig 9 is subjected to removal of a native oxide film and then hydrogen bonding. The resultant heat remains in jig and makes it difficult to maintain the wafers to temperature appropriate to removal of a native oxide film. [Means for Solution] After treatment of hydrogen bonding, inert gas having temperature of from 0 to ?30° C. is injected into reaction vessel 5 and/or treatment preparing vessel 21, in which a native oxide film has been removed.
    Type: Application
    Filed: August 15, 2006
    Publication date: May 7, 2009
    Inventors: Mikio Takagi, Seiichi Takahashi, Hiroaki Inoue, Masayuki Satou, Yutaka Miura
  • Publication number: 20090004647
    Abstract: Means for easily determining the grade of malignancy of cancer cells. The amount of ATBF1 in the whole cell structure of test cancer cells separated from a living organism is detected, and on the basis of detection results, the grade of malignancy of test cancer cells is judged. Alternatively, the amount of ATBF1 in the nuclei of test cancer cells separated from a living organism is detected, and on the basis of detection results, the grade of malignancy of test cancer cells is judged. Still alternatively, the amount of ATBF1 in the cytoplasms of test cancer cells separated from a living organism is detected, and on the basis of detection results, the grade of malignancy of test cancer cells is judged.
    Type: Application
    Filed: July 29, 2005
    Publication date: January 1, 2009
    Inventors: Yutaka Miura, Makoto Kawaguchi, Hirotaka Iwase, Minoru Hamazaki, Jung Cha-Gyun, Hitoo Nishino
  • Publication number: 20080282977
    Abstract: A process gas line (255) for carrying WF6 gas for nucleation, a process gas line (259) for carrying WF6 gas for film deposition after nucleation are joined at a single joint (280) to a carrier gas line (256). A gas line (270) is connected to the joint (280) to carry a mixed gas of the carrier gas and WF6 gas to a processing chamber defined by a processing vessel. Sections of the carrier gas line (256) and the gas line (270) extending on the opposite sides of the joint (280) extend along a straight line, and the process gas lines (255, 259) are perpendicular to the gas line (270).
    Type: Application
    Filed: April 18, 2008
    Publication date: November 20, 2008
    Inventors: Hayashi Otsuki, Yutaka Miura
  • Patent number: 7393404
    Abstract: A pigment dispersant contains the following component (a) alone or the following components (a) and (b) in combination: Component (a): a composite pigment formed of a diketopyrrolopyrrole pigment having a sulfonic group and another diketopyrrolopyrrole pigment having no sulfonic group, wherein the number of sulfonic group per molecule of the diketopyrrolopyrrole pigments in the composite pigment is from 0.05 to 0.5; and Component (b): a pigment other than the component (a), wherein the pigment has a sulfonic group or its metal salt, ammonium salt or amine salt. Also disclosed are a colored composition for color filters, a process for the fabrication of a color filter, the color filter fabricated by the process, an image display device including the color filter, and an information communication equipment including the image display device.
    Type: Grant
    Filed: February 15, 2006
    Date of Patent: July 1, 2008
    Assignee: Dainichiseika Color & Chemicals Mfg. Co., Ltd.
    Inventors: Hiroaki Saikatsu, Hiromitsu Yanagimoto, Naoto Kamata, Kazuhito Ooki, Yutaka Miura, Shigeru Sakamoto, Akio Yoshida, Michiei Nakamura
  • Publication number: 20070117864
    Abstract: The present invention provides a liver cancer prophylactic and therapeutic composition, and the present invention relates to a liver cancer prophylactic and therapeutic composition characterized in that this composition contains compounds that have a hepatoma proliferation inhibiting effect as active ingredients, these compounds comprising enterolactone (ENL) or plant lignan precursors of the same; a liver cancer prophylactic and therapeutic drug characterized in that this drug comprises compounds that have a hepatoma proliferation inhibiting effect, these compounds being enterolactone (ENL) or plant lignan precursors of the same, and a pharmacologically permissible carrier component; and a functional food product material characterized in that this food product material is formed by mixing compounds that have a hepatoma proliferation inhibiting effect, these compounds being enterolactone (ENL) or plant lignan precursors of the same as functional components with a food product material.
    Type: Application
    Filed: December 24, 2004
    Publication date: May 24, 2007
    Applicant: Tokyo University of Agr. & Tech. TLO Co., Ltd.
    Inventors: Kazumi Yagasaki, Yutaka Miura, Daiki Miura, Risto Santti, Niina Saarinen
  • Publication number: 20070087426
    Abstract: The invention provides a novel transferase that acts on a saccharide, as a substrate, composed of at least three sugar units wherein at least three glucose residues on the reducing end are linked ?-1,4 so as to transfer the ?-1,4 lingages to a ?-1, ?-1 linkages; a process for producing the transferase; a gene coding for the same; and a process for producing an oligosaccharide by using the same.
    Type: Application
    Filed: September 26, 2006
    Publication date: April 19, 2007
    Inventors: Masaru Kato, Yutaka Miura, Masako Kettoku, Akihiro Iwamatsu, Kazuo Kobayashi, Toshihiro Komeda